These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 7295998)

  • 21. Immunologic demonstration of a deficiency of Hageman factor-like material in Hageman trait.
    Smink MM; Daniel TM; Ratnoff OD; Stavitsky AB
    J Lab Clin Med; 1967 May; 69(5):819-32. PubMed ID: 4960805
    [No Abstract]   [Full Text] [Related]  

  • 22. Factor XII gene alteration in Hageman trait detected by TaqI restriction enzyme.
    Bernardi F; Marchetti G; Patracchini P; del Senno L; Tripodi M; Fantoni A; Bartolai S; Vannini F; Felloni L; Rossi L
    Blood; 1987 May; 69(5):1421-4. PubMed ID: 2882793
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Participation of Hageman factor dependent pathways in human disease states.
    Colman RW; Wong PY
    Thromb Haemost; 1977 Dec; 38(4):751-75. PubMed ID: 341410
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reduced titers of Hageman factor (factor XII) in Orientals.
    Gordon EM; Donaldson VH; Saito H; Su E; Ratnoff OD
    Ann Intern Med; 1981 Dec; 95(6):697-700. PubMed ID: 7305148
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The autoactivation of rabbit Hageman factor.
    Wiggins RC; Cochrane CC
    J Exp Med; 1979 Nov; 150(5):1122-33. PubMed ID: 501286
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Apnea and bradycardia due to anaphylaxis to tobacco glycoprotein in the infant rabbit.
    Gershan WM; Becker CG; Forster HV; Besch NS; Lowry TF
    Environ Res; 2004 Feb; 94(2):152-9. PubMed ID: 14757378
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunoquantitation of Hageman factor in urine and plasma of children with nephrotic syndrome.
    Hruby MA; Honig GR; Shapira E
    J Lab Clin Med; 1980 Sep; 96(3):501-10. PubMed ID: 6772722
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Significance of Hageman factor (coagulation factor XII) for neutrophil locomotion and chemotaxis.
    Keller HU; Beck EA; Hess MW; Cottier H
    Int Arch Allergy Appl Immunol; 1977; 55(1-6):309-13. PubMed ID: 591099
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Preparation of beta-XIIa (Hageman factor fragment) from human plasma.
    Tankersley DL; Alving BM; Finlayson JS
    Thromb Res; 1982 Feb; 25(4):307-17. PubMed ID: 6978550
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Initiation of contact activation by sulfatides.
    Tans G; Griffin JH
    Adv Exp Med Biol; 1983; 156():63-72. PubMed ID: 6602464
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Properties of sulfatides in factor-XII-dependent contact activation.
    Tans G; Griffin JH
    Blood; 1982 Jan; 59(1):69-75. PubMed ID: 6914902
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Williams trait. Human kininogen deficiency with diminished levels of plasminogen proactivator and prekallikrein associated with abnormalities of the Hageman factor-dependent pathways.
    Colman RW; Bagdasarian A; Talamo RC; Scott CF; Seavey M; Guimaraes JA; Pierce JV; Kaplan AP
    J Clin Invest; 1975 Dec; 56(6):1650-62. PubMed ID: 1202089
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of the clotting defect in a factor XII-deficient kindred.
    Chistolini A; Mazzucconi MG; Motta M; Solinas S; Tirindelli MC; Mariani G
    Ric Clin Lab; 1985; 15(3):241-5. PubMed ID: 3853270
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Activation and function of human Hageman factor. The role of high molecular weight kininogen and prekallikrein.
    Meier HL; Pierce JV; Colman RW; Kaplan AP
    J Clin Invest; 1977 Jul; 60(1):18-31. PubMed ID: 874082
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Autoantibodies to contact proteins in patients with recurrent pregnancy losses.
    Sugi T; Makino T
    J Reprod Immunol; 2002 Jan; 53(1-2):269-77. PubMed ID: 11730922
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Factor XII (Hageman Factor) Deficiency: a rare harbinger of life threatening complications.
    Chaudhry LA; El-Sadek WYM; Chaudhry GA; Al-Atawi FE
    Pan Afr Med J; 2019; 33():39. PubMed ID: 31384354
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Use of chromogenic substrates in the clarification of disorders in the early stages of blood coagulation].
    Vogel G; Stürzebecher J; Klessen C; Lauten G
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1982; 109(1):115-20. PubMed ID: 6177592
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Defective intrinsic fibrinolytic activity in a patient with severe factor XII-deficiency and myocardial infarction.
    Lodi S; Isa L; Pollini E; Bravo AF; Scalvini A
    Scand J Haematol; 1984 Jul; 33(1):80-2. PubMed ID: 6463588
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Studies on some coagulation factors (Hageman factor, plasma prekallikrein, and high molecular weight kininogen) in the normal newborn.
    Gordon EM; Ratnoff OD; Saito H; Gross S; Jones PK
    Am J Pediatr Hematol Oncol; 1980; 2(3):213-6. PubMed ID: 7435882
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Factor XII Osaka: abnormal factor XII with partially defective prekallikrein cleavage activity.
    Iijima K; Arakawa Y; Sugahara Y; Matsushita M; Moriguchi Y; Shimohiro H; Nakagawa M
    Thromb Haemost; 2011 Mar; 105(3):473-8. PubMed ID: 21264442
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.